Novel Research Pits Generic versus Brand Drugs for Epilepsy
For immediate release: October 21, 2013
What’s the difference between a brand-name medication and a generic version? For epilepsy patients — whose ability to control seizures is at stake — University of Maryland investigators are attempting to pinpoint the answer in novel, FDA-funded research on anti-epileptic drugs that may eventually change government requirements for generic drugs.
For more information see the full article in the latest edition of MD Rounds.
This page was last updated: October 21, 2013